Therapies for atopic dermatitis for special populations of patients
In this MEDtalk, April Armstrong, Professor, Associate Dean for Clinical Research at the University of Southern California, gives her perspective on four different groups of patients and how the therapies for atopic dermatitis, biologics, and JAK-inhibitors, may affect patients.
The four groups are:
1. Geriatric patients
2. Patients with potentially cardiovascular risk factors
3. Compromised patients
4. Pediatric patients